Neslihan Yilmaz
Overview
Explore the profile of Neslihan Yilmaz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Uslu S, Gulle S, Sen G, Capar S, Senel S, Dalkilic E, et al.
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685726
CT-P13 is a biosimilar version of infliximab, a monoclonal antibody. In individuals with ankylosing spondylitis (AS), CT-P13 has been shown to be effective and to have a well-tolerated safety profile....
2.
Ucer M, Cengiz B, Sahin S, Yavuz S, Yilmaz N
Eur J Rheumatol
. 2024 Nov;
11(1):8-12.
PMID: 39575906
Background: Atherosclerosis is increased in patients with rheumatoid arthritis (RA) and early diagnosis of vascular disease leads to better outcome. Our aim was to evaluate whether aortic elasticity decreases in...
3.
Kalabalik F, Yilmaz N, Aydin E, Aytugar E
J Dent Sci
. 2024 Sep;
19(4):2172-2178.
PMID: 39347050
Background/purpose: The objective of this study was to assess the root apical closure ages of first permanent molars retrospectively among a group of western Turkish children aged between 5 and...
4.
Celegen K, Gulhan B, Fidan K, Yuksel S, Yilmaz N, Yilmaz A, et al.
Clin Exp Nephrol
. 2024 Jul;
28(10):1038-1039.
PMID: 38970651
No abstract available.
5.
Bolla E, Semb A, Kerola A, Ikdahl E, Petri M, Pons-Estel G, et al.
Lancet Rheumatol
. 2024 Jun;
6(7):e447-e459.
PMID: 38878780
Background: Systemic lupus erythematosus (SLE) is characterised by increased cardiovascular morbidity and mortality risk. We aimed to examine the prevalence of traditional cardiovascular risk factors and their control in an...
6.
Bilgin E, Demirci Yildirim T, Ulusoy B, Ogut T, Karabacak M, Cagdas O, et al.
Intern Emerg Med
. 2024 May;
19(5):1517.
PMID: 38814522
No abstract available.
7.
Celegen K, Gulhan B, Fidan K, Yuksel S, Yilmaz N, Yilmaz A, et al.
Clin Exp Nephrol
. 2024 May;
28(10):1027-1037.
PMID: 38704765
Background: Atypical hemolytic uremic syndrome (aHUS) is a rare, mostly complement-mediated thrombotic microangiopathy. The majority of patients are infants. In contrast to infantile-onset aHUS, the clinical and genetic characteristics of...
8.
Bilgin E, Demirci Yildirim T, Ulusoy B, Ogut T, Karabacak M, Cagdas O, et al.
Intern Emerg Med
. 2024 Mar;
19(4):1025-1034.
PMID: 38553624
To investigate cancer incidence in patients with ANCA-associated vasculitis (AAV), compare it with the age/sex-specific cancer risk of the Turkish population, and explore independent risk factors associated with cancer. This...
9.
Yilmaz N, Polat R, Gursoy M, Kaman W, Aydin E, Fteita D, et al.
J Periodontol
. 2023 Jan;
94(7):896-904.
PMID: 36601897
Background: This cross-sectional study aimed to evaluate salivary concentrations of macrophage activation-related chemokines and mitogen-activated kinase kinase (MAPKK)-degrading proteolytic activity in children and adolescents with and without type 1 diabetes...
10.
Ornbjerg L, Rugbjerg K, Georgiadis S, Rasmussen S, Lindstrom U, Pavelka K, et al.
J Rheumatol
. 2022 Dec;
50(8):1009-1019.
PMID: 36455943
Objective: To investigate the distribution of patient-reported outcomes (PROs) in patients with axial spondyloarthritis (axSpA) initiating a tumor necrosis factor inhibitor (TNFi), to assess the proportion reaching PRO "remission" across...